• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺眼病治疗的心理社会结局有哪些?一项系统评价。

What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic review.

作者信息

Wickwar Sadie, McBain Hayley B, Ezra Daniel G, Hirani Shashivadan P, Rose Geoffrey E, Newman Stanton P

机构信息

1 City University London , School of Health Sciences, London, United Kingdom .

出版信息

Thyroid. 2014 Sep;24(9):1407-18. doi: 10.1089/thy.2014.0037. Epub 2014 Aug 1.

DOI:10.1089/thy.2014.0037
PMID:24967886
Abstract

BACKGROUND

Thyroid eye disease (TED) causes a number of esthetic and visual problems, and its treatment requires close clinical assessment, often for several years. There is evidence to suggest that clinical factors are poor indicators of patient-reported outcomes after treatments that aim to improve appearance, vision, or both. Psychosocial factors can impact on both adjustment to living with TED and also patients' perceptions of their improvements after treatment. There has been growing recognition that it is essential to evaluate treatment efficacy in terms of psychosocial outcomes, but, to date, there has been no review that has systematically evaluated psychosocial outcomes following a variety of treatments for TED.

SUMMARY

Fifteen studies were included in the review, and six were randomized controlled trials. The studies varied greatly in methodological rigor; whilst major treatments such as surgery do improve quality of life outcomes, other noninvasive treatments such as intravenous steroids can have a similar impact and show long-term benefits. Only three studies reviewed orbital decompressive surgery, which showed better psychosocial outcomes than other types of surgery.

CONCLUSIONS

The effect of some treatments remains unclear due to poor methodology and poor reporting of results. Clinicians need to be aware when planning rehabilitative treatments such as surgery of the influence of psychosocial factors on quality of life outcomes and the lack of a relationship with clinical factors such as disease severity.

摘要

背景

甲状腺眼病(TED)会引发一系列美学和视觉问题,其治疗需要密切的临床评估,通常持续数年。有证据表明,在旨在改善外观、视力或两者的治疗后,临床因素并不能很好地指示患者报告的结果。心理社会因素既会影响患者对TED生活的适应,也会影响患者对治疗后改善情况的认知。人们越来越认识到,从心理社会结果的角度评估治疗效果至关重要,但迄今为止,尚无综述系统地评估过针对TED的各种治疗后的心理社会结果。

总结

该综述纳入了15项研究,其中6项为随机对照试验。这些研究在方法严谨性上差异很大;虽然手术等主要治疗方法确实能改善生活质量结果,但静脉注射类固醇等其他非侵入性治疗也能产生类似影响并显示出长期益处。仅有3项研究对眼眶减压手术进行了综述,结果显示其心理社会结果优于其他类型的手术。

结论

由于方法欠佳和结果报告不充分,一些治疗的效果仍不明确。临床医生在计划诸如手术等康复治疗时,需要意识到心理社会因素对生活质量结果的影响,以及与疾病严重程度等临床因素缺乏关联。

相似文献

1
What are the psychosocial outcomes of treatment for thyroid eye disease? A systematic review.甲状腺眼病治疗的心理社会结局有哪些?一项系统评价。
Thyroid. 2014 Sep;24(9):1407-18. doi: 10.1089/thy.2014.0037. Epub 2014 Aug 1.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
Surgical orbital decompression for thyroid eye disease.甲状腺眼病的眼眶减压手术
Cochrane Database Syst Rev. 2011 Dec 7(12):CD007630. doi: 10.1002/14651858.CD007630.pub2.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Parent-training programmes for improving maternal psychosocial health.改善孕产妇心理社会健康的家长培训项目。
Cochrane Database Syst Rev. 2004(1):CD002020. doi: 10.1002/14651858.CD002020.pub2.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

引用本文的文献

1
Impact of graves'ophthalmopathy on quality of life, depression, and anxiety among turkish patients.格雷夫斯眼病对土耳其患者生活质量、抑郁和焦虑的影响。
Ir J Med Sci. 2025 Jul 19. doi: 10.1007/s11845-025-04015-1.
2
Quality and content evaluation of thyroid eye disease treatment information on TikTok and Bilibili.TikTok和哔哩哔哩上甲状腺眼病治疗信息的质量与内容评估
Sci Rep. 2025 Jul 11;15(1):25134. doi: 10.1038/s41598-025-11147-y.
3
Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions - a systematic review.
格雷夫斯眼病:不同医学干预的临床和社会心理结局——系统评价。
BMJ Open Ophthalmol. 2024 Jun 17;9(1):e001515. doi: 10.1136/bmjophth-2023-001515.
4
Changing the face of thyroid eye disease.改变甲状腺眼病的面貌。
Eye (Lond). 2023 Feb;37(2):197-199. doi: 10.1038/s41433-022-02186-0. Epub 2022 Jul 26.
5
The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves' orbitopathy.泪腺SPECT/CT成像作为评估Graves眼病活动度方法的价值。
Endocr Connect. 2022 Feb 9;11(2):e210590. doi: 10.1530/EC-21-0590.
6
Long-term outcomes in corticosteroid-refractory Graves' orbitopathy treated with tocilizumab.托珠单抗治疗糖皮质激素抵抗性格雷夫斯眼病的长期疗效。
Clin Endocrinol (Oxf). 2022 Sep;97(3):363-370. doi: 10.1111/cen.14655. Epub 2021 Dec 14.
7
A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.多学科甲状腺眼病服务的“真实生活”服务评估模型。
Front Endocrinol (Lausanne). 2021 May 7;12:669871. doi: 10.3389/fendo.2021.669871. eCollection 2021.
8
Improvement of asymmetric thyroid eye disease with teprotumumab.特普西单抗改善非对称性甲状腺眼病。
Br J Ophthalmol. 2022 Jun;106(6):755-759. doi: 10.1136/bjophthalmol-2020-318314. Epub 2021 Feb 12.
9
Mechanisms of Spica Prunellae against thyroid-associated Ophthalmopathy based on network pharmacology and molecular docking.基于网络药理学和分子对接的夏枯草治疗甲状腺相关眼病的作用机制。
BMC Complement Med Ther. 2020 Jul 20;20(1):229. doi: 10.1186/s12906-020-03022-2.
10
Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review.甲状腺相关性眼病进展与管理的当前认识:一项系统评价
Ophthalmol Ther. 2020 Mar;9(1):21-33. doi: 10.1007/s40123-019-00226-9. Epub 2019 Dec 10.